Lab Automation in Protein Engineering Market Share

Statistics for the 2023 & 2024 Lab Automation in Protein Engineering market share, created by Mordor Intelligence™ Industry Reports. Lab Automation in Protein Engineering share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Lab Automation in Protein Engineering Industry

The lab automation in protein engineering market is moderately competitive, owing to many small and big players exporting products to many countries. The key strategies adopted by the major players are technological advancement in development, partnerships, and merger and acquisition. Some of the major players in the market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens Healthineers, Danaher Corporation, and PerkinElmer. Some of the recent developments in the market are:

  • January 2023 - BD (Becton, Dickinson and Company), a leading medical technology provider, unveiled a new robotic track system for the BD Kiestra microbiology laboratory solution worldwide. This system automates the processing of lab specimens, which could help to cut down on manual labor. The new BD Kiestra 3rd Generation Complete Lab Automation System is expandable to fit the specific demands of labs and allows them to connect several BD Kiestra modules in a flexible and customized total lab automation configuration.

Lab Automation in Protein Engineering Market Leaders

  1. Agilent Technologies Inc.

  2. Thermo Fisher Scientific

  3. PerkinElmer, Inc.

  4. Beckman Coulter Inc.

  5. Roche Holding AG

*Disclaimer: Major Players sorted in no particular order

Lab Automation in Protein Engineering Market Concentration

Lab Automation in Protein Engineering Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)